Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a DNA immunoadsorbent: coupling DNA on sepharose 4FF by an efficient activation method.

D L Kong1, W Schuett, H F Boeden

  • 1R&D Center of Bioengineering, Rostock, Germany.

Artificial Organs
|December 19, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Ultra-long-term follow-up of renal denervation in patients with resistant hypertension and mild chronic kidney disease].

Zhonghua xin xue guan bing za zhi·2025
Same author

MOF-derived Ag<sub>0.16</sub>/In<sub>1.95</sub>Pr<sub>0.05</sub>O<sub>3</sub> sensors with ultra-high sensitivity, quick response and excellent selectivity to formaldehyde gas.

Talanta·2024
Same author

[Clinicopathological features and prognosis of colorectal stromal tumor].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2020
Same author

Association between mucopolysaccharidosis Type VII and hydrops fetalis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same author

[Analysis of characteristics and influence factors of diagnostic delay of endometriosis].

Zhonghua fu chan ke za zhi·2018
Same author

Photosensitizer-induced self-assembly of antigens as nanovaccines for cancer immunotherapy.

Biomaterials science·2018

A novel DNA immunoadsorbent effectively removes anti-DNA antibodies from systemic lupus erythematosus (SLE) plasma. This affinity chromatography method significantly reduces antibody levels, offering a potential therapeutic approach for SLE patients.

Area of Science:

  • Biochemistry
  • Immunology
  • Materials Science

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of anti-DNA antibodies.
  • Removing these antibodies from patient plasma could be a therapeutic strategy for SLE.
  • Affinity chromatography offers a method for targeted removal of specific antibodies.

Purpose of the Study:

  • To develop and characterize a DNA immunoadsorbent for the removal of anti-DNA antibodies from SLE patient plasma.
  • To optimize the coupling of DNA to an activated Sepharose support for enhanced binding capacity.
  • To evaluate the efficacy and specificity of the developed immunoadsorbent in reducing anti-DNA antibody levels.

Main Methods:

  • Covalent coupling of calf thymus DNA to Sepharose 4FF activated with 5-norbornene-2,3-dicarboximido carbonochloridate (Cl-CO-ONB).

Related Experiment Videos

  • Optimization of DNA coupling conditions including pH, temperature, time, DNA concentration, and activation level.
  • Incubation of SLE patient plasma with the DNA immunoadsorbent and measurement of anti-DNA antibody reduction.

    • Main Results:

    • The optimal pH for DNA coupling was determined to be 3.0.
    • Maximum DNA coupling capacity reached 1.0 mg DNA/ml of support.
    • Incubation with the immunoadsorbent reduced anti-DNA antibody levels by 80-90% in SLE plasma.
    • Nonspecific adsorption of normal IgG and total protein was minimal (<15%).

    Conclusions:

    • A highly effective DNA immunoadsorbent was successfully prepared using activated Sepharose 4FF.
    • The developed method demonstrates significant potential for the extracorporeal removal of anti-DNA antibodies in SLE treatment.
    • This approach offers a promising avenue for managing autoimmune diseases driven by specific autoantibodies.